1
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar
|
2
|
Ding SZ, Goldberg JB and Hatakeyama M:
Helicobacter pylori infection, oncogenic pathways and
epigenetic mechanisms in gastric carcinogenesis. Future Oncol.
6:851–862. 2010. View Article : Google Scholar
|
3
|
Merchant JL, Saqui-Salces M and El-Zaatari
M: Hedgehog signaling in gastric physiology and cancer. Prog Mol
Biol Transl Sci. 96:133–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Martin J, Donnelly JM, Houghton J and
Zavros Y: The role of sonic hedgehog reemergence during gastric
cancer. Dig Dis Sci. 55:1516–1524. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Varjosalo M and Taipale J: Hedgehog:
functions and mechanisms. Genes Dev. 22:2454–2472. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Yang L, Xie G, Fan Q and Xie J: Activation
of the hedgehog-signaling pathway in human cancer and the clinical
implications. Oncogene. 29:469–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Scales SJ and de Sauvage FJ: Mechanisms of
Hedgehog pathway activation in cancer and implications for therapy.
Trends Pharmacol Sci. 30:303–312. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ma X, Chen K, Huang S, et al: Frequent
activation of the hedgehog pathway in advanced gastric
adenocarcinomas. Carcinogenesis. 26:1698–1705. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hooper JE and Scott MP: Communicating with
Hedgehogs. Nat Rev Mol Cell Biol. 6:306–317. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Huangfu D and Anderson KV: Signaling from
Smo to Ci/Gli: conservation and divergence of Hedgehog pathways
from Drosophila to vertebrates. Development. 133:3–14. 2006.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Osterlund T and Kogerman P: Hedgehog
signalling: how to get from Smo to Ci and Gli. Trends Cell Biol.
16:176–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lin X: Functions of heparan sulfate
proteoglycans in cell signaling during development. Development.
131:6009–6021. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Morimoto-Tomita M, Uchimura K, Werb Z,
Hemmerich S and Rosen SD: Cloning and characterization of two
extracellular heparin-degrading endosulfatases in mice and humans.
J Biol Chem. 277:49175–49185. 2002. View Article : Google Scholar : PubMed/NCBI
|
14
|
Bernfield M, Gotte M, Park PW, et al:
Functions of cell surface heparan sulfate proteoglycans. Annu Rev
Biochem. 68:729–777. 1999. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lai J, Chien J, Staub J, et al: Loss of
HSulf-1 up-regulates heparin-binding growth factor signaling in
cancer. J Biol Chem. 278:23107–23117. 2003. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lai JP, Chien JR, Moser DR, et al: hSulf1
Sulfatase promotes apoptosis of hepatocellular cancer cells by
decreasing heparin-binding growth factor signaling.
Gastroenterology. 126:231–248. 2004. View Article : Google Scholar
|
17
|
Lai JP, Sandhu DS, Shire AM and Roberts
LR: The tumor suppressor function of human sulfatase 1 (SULF1) in
carcinogenesis. J Gastrointest Cancer. 39:149–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Narita K, Staub J, Chien J, et al: HSulf-1
inhibits angiogenesis and tumorigenesis in vivo. Cancer Res.
66:6025–6032. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Dai Y, Yang Y, MacLeod V, et al: HSulf-1
and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo.
J Biol Chem. 280:40066–40073. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Lai JP, Chien J, Strome SE, et al: HSulf-1
modulates HGF-mediated tumor cell invasion and signaling in head
and neck squamous carcinoma. Oncogene. 23:1439–1447. 2004.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Lai JP, Sandhu DS, Moser CD, et al:
Additive effect of apicidin and doxorubicin in sulfatase 1
expressing hepatocellular carcinoma in vitro and in vivo. J
Hepatol. 50:1112–1121. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chen Z, Fan JQ, Li J, et al: Promoter
hypermethylation correlates with the Hsulf-1 silencing in human
breast and gastric cancer. Int J Cancer. 124:739–744. 2009.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Li J, Kleeff J, Abiatari I, et al:
Enhanced levels of Hsulf-1 interfere with heparin-binding growth
factor signaling in pancreatic cancer. Mol Cancer. 4:142005.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Abiatari I, Kleeff J, Li J, Felix K,
Buchler MW and Friess H: Hsulf-1 regulates growth and invasion of
pancreatic cancer cells. J Clin Pathol. 59:1052–1058. 2006.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Dhoot GK, Gustafsson MK, Ai X, Sun W,
Standiford DM and Emerson CP Jr: Regulation of Wnt signaling and
embryo patterning by an extracellular sulfatase. Science.
293:1663–1666. 2001. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chuang PT, Kawcak T and McMahon AP:
Feedback control of mammalian Hedgehog signaling by the
Hedgehog-binding protein, Hip1, modulates Fgf signaling during
branching morphogenesis of the lung. Genes Dev. 17:342–347. 2003.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Chuang PT and McMahon AP: Vertebrate
Hedgehog signalling modulated by induction of a Hedgehog-binding
protein. Nature. 397:617–621. 1999. View
Article : Google Scholar : PubMed/NCBI
|
28
|
Katoh Y and Katoh M: Hedgehog target
genes: mechanisms of carcinogenesis induced by aberrant hedgehog
signaling activation. Curr Mol Med. 9:873–886. 2009. View Article : Google Scholar : PubMed/NCBI
|
29
|
Rao G, Pedone CA, Coffin CM, Holland EC
and Fults DW: c-Myc enhances sonic hedgehog-induced medulloblastoma
formation from nestin-expressing neural progenitors in mice.
Neoplasia. 5:198–204. 2003. View Article : Google Scholar : PubMed/NCBI
|
30
|
Sherr CJ and Roberts JM: CDK inhibitors:
positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
31
|
Bigelow RL, Chari NS, Unden AB, et al:
Transcriptional regulation of bcl-2 mediated by the sonic hedgehog
signaling pathway through gli-1. J Biol Chem. 279:1197–1205. 2004.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Lai JP, Yu C, Moser CD, et al: SULF1
inhibits tumor growth and potentiates the effects of histone
deacetylase inhibitors in hepatocellular carcinoma.
Gastroenterology. 130:2130–2144. 2006. View Article : Google Scholar : PubMed/NCBI
|
33
|
Staub J, Chien J, Pan Y, et al: Epigenetic
silencing of HSulf-1 in ovarian cancer:implications in
chemoresistance. Oncogene. 26:4969–4978. 2007. View Article : Google Scholar : PubMed/NCBI
|
34
|
Lai JP, Thompson JR, Sandhu DS and Roberts
LR: Heparin-degrading sulfatases in hepatocellular carcinoma: roles
in pathogenesis and therapy targets. Future Oncol. 4:803–814. 2008.
View Article : Google Scholar : PubMed/NCBI
|